Olivier Danos

Insider Reports History

Entity
Individual
Location
C/O Regenxbio Inc., 9804 Medical Center Drive, Rockville, MD
Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Olivier Danos:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENXBIO Inc. Chief Scientific Officer Common Stock 185K $2.78M $15.05 Aug 1, 2024 Direct
REGENXBIO Inc. Chief Scientific Officer Stock Options (Right to buy) 61.1K Jan 2, 2024 Direct

Insider Reports Filed by Olivier Danos

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGNX REGENXBIO Inc. Aug 1, 2024 2 $13.6K 4 Aug 5, 2024 Chief Scientific Officer
RGNX REGENXBIO Inc. Jan 2, 2024 5 -$117K 4 Jan 4, 2024 Chief Scientific Officer
RGNX REGENXBIO Inc. Jan 3, 2023 3 -$46.7K 4 Jan 5, 2023 Chief Scientific Officer
RGNX REGENXBIO Inc. Jan 1, 2022 5 -$21.6K 4 Jan 4, 2022 Chief Scientific Officer